Neurodegeneration in autoimmune CNS inflammation

Experimental Neurology

Volumn 225, Issue 1, 2010, Pages 9-17

  Herz, Josephine ^a,b   Zipp, Frauke ^a,b   Siffrin, Volker ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

CNS inflammation; EAE; Inflammatory neurodegeneration; Multiple Sclerosis; Neuronal axonal damage

Indexed keywords

7 OXOCHOLESTEROL; BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPIGALLOCATECHIN GALLATE; FLECAINIDE; FLUPIRTINE; GLATIRAMER; INTERLEUKIN 1BETA; LAMOTRIGINE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROFILAMENT M PROTEIN; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADD ON THERAPY; ALLERGIC ENCEPHALITIS; ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AUTOPSY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MICROGLIA; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; INFLAMMATION; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION;

EID: 77955659717     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.11.019     Document Type: Review

References (140)

1. Aktas O., Prozorovski T., Smorodchenko A., Savaskan N.E., Lauster R., Kloetzel P.M., Infante-Duarte C., Brocke S., Zipp F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 2004, 173:5794-5800.
2. Aktas O., Smorodchenko A., Brocke S., Infante-Duarte C., Schulze T.U., Vogt J., Prozorovski T., Meier S., Osmanova V., Pohl E., Bechmann I., Nitsch R., Zipp F. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 2005, 46:421-432.
3. Aktas O., Schulze-Topphoff U., Zipp F. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front. Biosci. 2007, 12:2912-2921.
4. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
5. Anderton S.M., Liblau R.S. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 2008, 21:248-254.
6. Anthony D.C., Ferguson B., Matyzak M.K., Miller K.M., Esiri M.M., Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 1997, 23:406-415.
7. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
8. Barth B.M., Stewart-Smeets S., Kuhn T.B. Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol. Cell Neurosci. 2009, 41:274-285.
9. Bechmann I., Goldmann J., Kovac A.D., Kwidzinski E., Simburger E., Naftolin F., Dirnagl U., Nitsch R., Priller J. Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J. 2005, 19:647-649.
10. Bechtold D.A., Kapoor R., Smith K.J. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann. Neurol. 2004, 55:607-616.
11. Bechtold D.A., Miller S.J., Dawson A.C., Sun Y., Kapoor R., Berry D., Smith K.J. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J. Neurol. 2006, 253:1542-1551.
12. Bettelli E., Baeten D., Jager A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006, 116:2393-2402.
13. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123(Pt. 6):1174-1183.
14. Bjartmar C., Kidd G., Mork S., Rudick R., Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 2000, 48:893-901.
15. Block F., Pergande G., Schwarz M. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res. 1997, 754:279-284.
16. Bo L., Vedeler C.A., Nyland H., Trapp B.D., Mork S.J. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult. Scler. 2003, 9:323-331.
17. Brochard V., Combadiere B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J.M., Duyckaerts C., Flavell R.A., Hirsch E.C., Hunot S. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 2009, 119:182-192.
18. Brown G.C., Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 2002, 33:1440-1450.
19. Calabrese M., Atzori M., Bernardi V., Morra A., Romualdi C., Rinaldi L., McAuliffe M.J., Barachino L., Perini P., Fischl B., Battistin L., Gallo P. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J. Neurol. 2007, 254:1212-1220.
20. Carvey P.M., Chen E.Y., Lipton J.W., Tong C.W., Chang Q.A., Ling Z.D. Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J. Neural Transm. 2005, 112:601-612.
21. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 1995, 9:355-365.
22. Charil A., Dagher A., Lerch J.P., Zijdenbos A.P., Worsley K.J., Evans A.C. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 2007, 34:509-517.
23. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006, 354:610-621.
24. Chiang J.J., Truong K. Using co-cultures expressing fluorescence resonance energy transfer based protein biosensors to simultaneously image caspase-3 and Ca2+ signaling. Biotechnol. Lett. 2005, 27:1219-1227.
25. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
26. Craner M.J., Damarjian T.G., Liu S., Hains B.C., Lo A.C., Black J.A., Newcombe J., Cuzner M.L., Waxman S.G. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005, 49:220-229.
27. Curotto de Lafaille M.A., Lafaille J.J. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
28. DeLuca G.C., Williams K., Evangelou N., Ebers G.C., Esiri M.M. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006, 129:1507-1516.
29. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J., Francis G.S., Antel J.P., Arnold D.L. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998, 121(Pt. 8):1469-1477.
30. Diestel A., Aktas O., Hackel D., Hake I., Meier S., Raine C.S., Nitsch R., Zipp F., Ullrich O. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J. Exp. Med. 2003, 198:1729-1740.
31. Dorr J., Bechmann I., Waiczies S., Aktas O., Walczak H., Krammer P.H., Nitsch R., Zipp F. Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J. Neurosci. 2002, 22:RC209.
32. Dorr J., Roth K., Zurbuchen U., Deisz R., Bechmann I., Lehmann T.N., Meier S., Nitsch R., Zipp F. Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate. J. Neuroimmunol. 2005, 167:204-209.
33. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., Gudz T., Macklin W.B., Lewis D.A., Fox R.J., Rudick R., Mirnics K., Trapp B.D. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 2006, 59:478-489.
34. Ehrlich S., Infante-Duarte C., Seeger B., Zipp F. Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine 2003, 24:244-253.
35. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005, 26:485-495.
36. Farber K., Kettenmann H. Physiology of microglial cells. Brain Res. Brain Res. Rev. 2005, 48:133-143.
37. Felts P.A., Baker T.A., Smith K.J. Conduction in segmentally demyelinated mammalian central axons. J. Neurosci. 1997, 17:7267-7277.
38. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120(Pt. 3):393-399.
39. Fisher E., Chang A., Fox R.J., Tkach J.A., Svarovsky T., Nakamura K., Rudick R.A., Trapp B.D. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann. Neurol. 2007, 62:219-228.
40. Flugel A., Schwaiger F.W., Neumann H., Medana I., Willem M., Wekerle H., Kreutzberg G.W., Graeber M.B. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 2000, 10:353-364.
41. Friese M.A., Craner M.J., Etzensperger R., Vergo S., Wemmie J.A., Welsh M.J., Vincent A., Fugger L. Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat. Med. 2007, 13:1483-1489.
42. Frischer J.M., Bramow S., Dal Bianco A., Lucchinetti C.F., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132:1175-1189.
43. Furlan R., Bergami A., Brambilla E., Butti E., De Simoni M.G., Campagnoli M., Marconi P., Comi G., Martino G. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 2007, 14:93-98.
44. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 1995, 20:269-287.
45. Gibbons H.M., Dragunow M. Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res. 2006, 1084:1-15.
46. Giuliani F., Goodyer C.G., Antel J.P., Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 2003, 171:368-379.
47. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
48. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005, 11:328-334.
49. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
50. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
51. Haqqi T.M., Anthony D.D., Gupta S., Ahmad N., Lee M.S., Kumar G.K., Mukhtar H. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4524-4529.
52. Hendrix S., Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 2007, 184:100-112.
53. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., Waisman A., Rulicke T., Prinz M., Priller J., Becher B., Aguzzi A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 2005, 11:146-152.
54. Hilliard B., Wilmen A., Seidel C., Liu T.S., Goke R., Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 2001, 166:1314-1319.
55. Hohlfeld R., Kerschensteiner M., Meinl E. Dual role of inflammation in CNS disease. Neurology 2007, 68:S58-S63.
56. Huitinga I., van Rooijen N., de Groot C.J., Uitdehaag B.M., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 1990, 172:1025-1033.
57. Huizinga R., Heijmans N., Schubert P., Gschmeissner S., 't Hart B.A., Herrmann H., Amor S. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J. Neuropathol. Exp. Neurol. 2007, 66:295-304.
58. Huizinga R., Gerritsen W., Heijmans N., Amor S. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol. Dis. 2008, 32:461-470.
59. Iliev A.I., Stringaris A.K., Nau R., Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004, 18:412-414.
60. Kapoor R., Davies M., Blaker P.A., Hall S.M., Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 2003, 53:174-180.
61. Kassmann C.M., Lappe-Siefke C., Baes M., Brugger B., Mildner A., Werner H.B., Natt O., Michaelis T., Prinz M., Frahm J., Nave K.A. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 2007, 39:969-976.
62. Katiyar S.K., Challa A., McCormick T.S., Cooper K.D., Mukhtar H. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999, 20:2117-2124.
63. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
64. Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
65. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 2000, 157:267-276.
66. Kornek B., Storch M.K., Bauer J., Djamshidian A., Weissert R., Wallstroem E., Stefferl A., Zimprich F., Olsson T., Linington C., Schmidbauer M., Lassmann H. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001, 124:1114-1124.
67. Krishnamoorthy G., Lassmann H., Wekerle H., Holz A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 2006, 116:2385-2392.
68. Krishnamoorthy G., Saxena A., Mars L.T., Domingues H.S., Mentele R., Ben Nun A., Lassmann H., Dornmair K., Kurschus F.C., Liblau R.S., Wekerle H. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat. Med. 2009, 15:626-632.
69. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366-374.
70. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8514-8519.
71. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R., Weber J.R. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 2008, 28:2320-2331.
72. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 1999, 53:457-465. Lenercept.
73. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78:1073-1082.
74. Lindquist S., Bodammer N., Kaufmann J., Konig F., Heinze H.J., Bruck W., Sailer M. Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant. Mult. Scler. 2007, 13:471-482.
75. Liu Y., Teige I., Birnir B., Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 2006, 12:518-525.
76. Lo A.C., Saab C.Y., Black J.A., Waxman S.G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J. Neurophysiol. 2003, 90:3566-3571.
77. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
78. Lunemann J.D., Waiczies S., Ehrlich S., Wendling U., Seeger B., Kamradt T., Zipp F. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J. Immunol. 2002, 168:4881-4888.
79. Mahad D., Ziabreva I., Lassmann H., Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008, 131:1722-1735.
80. Mahad D.J., Ziabreva I., Campbell G., Lax N., White K., Hanson P.S., Lassmann H., Turnbull D.M. Mitochondrial changes within axons in multiple sclerosis. Brain 2009, 132:1161-1174.
81. Mank M., Santos A.F., Direnberger S., Mrsic-Flogel T.D., Hofer S.B., Stein V., Hendel T., Reiff D.F., Levelt C., Borst A., Bonhoeffer T., Hubener M., Griesbeck O. A genetically encoded calcium indicator for chronic in vivo two-photon imaging. Nat. Methods 2008, 5:805-811.
82. Maresz K., Pryce G., Ponomarev E.D., Marsicano G., Croxford J.L., Shriver L.P., Ledent C., Cheng X., Carrier E.J., Mann M.K., Giovannoni G., Pertwee R.G., Yamamura T., Buckley N.E., Hillard C.J., Lutz B., Baker D., Dittel B.N. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med. 2007, 13:492-497.
83. Marta M., Andersson A., Isaksson M., Kampe O., Lobell A. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2008, 38:565-575.
84. McGeachy M.J., Stephens L.A., Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 2005, 175:3025-3032.
85. Medana I.M., Gallimore A., Oxenius A., Martinic M.M., Wekerle H., Neumann H. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 2000, 30:3623-3633.
86. Medana I., Martinic M.A., Wekerle H., Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 2001, 159:809-815.
87. Mendel I., Kerlero d.R., Ben Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995, 25:1951-1959.
88. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., Bahr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 2001, 21:6214-6220.
89. Miller D.H., Leary S.M. Primary-progressive multiple sclerosis. Lancet Neurol 2007, 6:903-912.
90. Miller D.H., Barkhof F., Frank J.A., Parker G.J., Thompson A.J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002, 125:1676-1695.
91. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5:49-55.
92. Napoli, I., Neumann, H., in press. Protective effects of microglia in multiple sclerosis, Exp. Neurol., doi:10.1016/j.expneurol.2009.04.024.
93. Narayanan S., Francis S.J., Sled J.G., Santos A.C., Antel S., Levesque I., Brass S., Lapierre Y., Sappey-Marinier D., Pike G.B., Arnold D.L. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Neuroimage 2006, 29:637-642.
94. Nave K.A., Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 2008, 31:535-561.
95. Neumann H., Cavalie A., Jenne D.E., Wekerle H. Induction of MHC class I genes in neurons. Science 1995, 269:549-552.
96. Newman T.A., Woolley S.T., Hughes P.M., Sibson N.R., Anthony D.C., Perry V.H. T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 2001, 124:2203-2214.
97. Nikolaeva M.A., Mukherjee B., Stys P.K. Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J. Neurosci. 2005, 25:9960-9967.
98. Nitsch R., Bechmann I., Deisz R.A., Haas D., Lehmann T.N., Wendling U., Zipp F. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 2000, 356:827-828.
99. Nitsch R., Pohl E.E., Smorodchenko A., Infante-Duarte C., Aktas O., Zipp F. Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J. Neurosci. 2004, 24:2458-2464.
100. O'Connor P. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology 2002, 59:S1-33.
101. Okun E., Griffioen K.J., Lathia J.D., Tang S.C., Mattson M.P., Arumugam T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
102. O'Malley H.A., Shreiner A.B., Chen G.H., Huffnagle G.B., Isom L.L. Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis. Mol. Cell Neurosci. 2009, 40:143-155.
103. Papadopoulos D., Pham-Dinh D., Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 2006, 197:373-385.
104. Peterson J.W., Bo L., Mork S., Chang A., Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 2001, 50:389-400.
105. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 2000, 6:67-70.
106. Pollinger B., Krishnamoorthy G., Berer K., Lassmann H., Bosl M.R., Dunn R., Domingues H.S., Holz A., Kurschus F.C., Wekerle H. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 2009, 206:1303-1316.
107. Prinz M., Garbe F., Schmidt H., Mildner A., Gutcher I., Wolter K., Piesche M., Schroers R., Weiss E., Kirschning C.J., Rochford C.D., Bruck W., Becher B. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest 2006, 116:456-464.
108. Renganathan M., Cummins T.R., Waxman S.G. Nitric oxide blocks fast, slow, and persistent Na+ channels in C-type DRG neurons by S-nitrosylation. J. Neurophysiol. 2002, 87:761-775.
109. Renno T., Krakowski M., Piccirillo C., Lin J.Y., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 1995, 154:944-953.
110. Rensing-Ehl A., Malipiero U., Irmler M., Tschopp J., Constam D., Fontana A. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur. J. Immunol. 1996, 26:2271-2274.
111. Sajad M., Zargan J., Chawla R., Umar S., Sadaqat M., Khan H.A. Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol. Cell Biochem. 2009, 328:183-188.
112. Sattler M.B., Williams S.K., Neusch C., Otto M., Pehlke J.R., Bahr M., Diem R. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis. Am. J. Pathol. 2008, 173:1496-1507.
113. Schrempf W., Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 2007, 6:469-475.
114. Schroeder E.K., Kelsey N.A., Doyle J., Breed E., Bouchard R.J., Loucks A., Harbison A., Linseman D.A. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective anti-apoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid. Redox. Signal. 2009, 11(3):469-480.
115. Selmaj K.W., Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 1995, 45:S44-S49.
116. Sicotte N.L., Voskuhl R.R. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001, 57:1885-1888.
117. Siffrin V., Brandt A.U., Herz J., Zipp F. New insights into adaptive immunity in chronic neuroinflammation. Adv. Immunol. 2007, 96:1-40.
118. Siffrin V., Brandt A.U., Radbruch H., Herz J., Boldakowa N., Leuenberger T., Werr J., Hahner A., Schulze-Topphoff U., Nitsch R., Zipp F. Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. Brain 2009, 132:1247-1258.
119. Stadelmann C., Albert M., Wegner C., Bruck W. Cortical pathology in multiple sclerosis. Curr. Opin. Neurol. 2008, 21:229-234.
120. Stys P.K., Jiang Q. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci. Lett. 2002, 328:150-154.
121. Stys P.K., Waxman S.G., Ransom B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J. Neurosci. 1992, 12:430-439.
122. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
123. Suzuki M., Tabuchi M., Ikeda M., Umegaki K., Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med. Sci. Monit. 2004, 10:BR166-BR174.
124. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
125. Tian L., Rauvala H., Gahmberg C.G. Neuronal regulation of immune responses in the central nervous system. Trends Immunol 2009, 30:91-99.
126. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247-269.
127. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
128. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J. Neuroimmunol. 1983, 4:201-221.
129. Venters H.D., Dantzer R., Kelley K.W. Tumor necrosis factor-alpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann. N.Y. Acad. Sci. 2000, 917:210-220.
130. Vogt, J., Paul, F., Aktas, O., Müller-Wielsch, K., Dörr, J., Dörr, S., Bharathi, B.S., Glumm, R., Schmitz, C., Steinbusch, H., Raine, C.S., Tsokos, M., Nitsch, R., Zipp, F., 2009. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann. Neurol. 66, 310-322.
131. Waxman S.G. Nitric oxide and the axonal death cascade. Ann. Neurol. 2003, 53:150-153.
132. Waxman S.G. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Nat. Clin. Pract. Neurol. 2008, 4:159-169.
133. Wekerle H., Lassmann H., Linington C., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 1986, 9:271-277.
134. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., Shah B., Chang S.H., Schluns K.S., Watowich S.S., Feng X.H., Jetten A.M., Dong C. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
135. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 2003, 6:1064-1071.
136. Zhang B., Rusciano D., Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res 2008, 1198:141-152.
137. Zhang M., Martin B.R., Adler M.W., Razdan R.J., Kong W., Ganea D., Tuma R.F. Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. J. Neuroimmune. Pharmacol. 2009, 4:249-259.
138. Zipp F. Apoptosis in multiple sclerosis. Cell Tissue Res 2000, 301:163-171.
139. Zipp F., Krammer P.H., Weller M. Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. Immunol. Today 1999, 20:550-554.
140. Zozulya A.L., Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum. Immunol. 2008, 69:797-804.